The health agencies will then provide a recommendation to the DEA after considering the scientific evidence. Health Secretary Xavier Becerra stated in June that the aim is to complete this process by the end of the year. However, during the recent congressional hearing, DEA Administrator Anne Milgram was less definitive about the timeline, stating that she had yet to receive a specific timeframe for the consideration and rescheduling recommendation.
President Donald Trump has reignited the debate over cannabis policy in Washington, D.C., by linking…
Pink-Runtz has solidified its status as a designer strain worth mastering. This 50% India, 50%…
Find the best THCA strains to smoke this 420 and beyond. Leafly reviewed popular THCA…
A fascinating new study published in the Journal of Hand Surgery Global Online has revealed…
The transfer of The Hawthorne Collective to a strategic partner was made in exchange for…
A vape cartridge is essentially the most important feature of any vape pen. The cart…
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
